Philip M Polgreen

Dr. Philip M Polgreen

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ASAlessio Signorini
Alessio Signorini
ASAlberto Maria Segre
Alberto Maria Segre
PPPhilip M Polgreen
Philip M Polgreen
Twitter is a free social networking and micro-blogging service that enables its millions of users to send and read each other's “tweets,” or short, 140-character messages. The service has more than 190 million registered users and processes about 55 million tweets per day. Useful information about news and geopolitical events lies embedded in the Twitter stream, which embodies, in the aggregate, Twitter users' perspectives and reactions to current events. By virtue of sheer volume, content embedded in the Twitter stream may be useful for tracking or even forecasting behavior if it can be extracted in an efficient manner. In this study, we examine the use of information embedded in the Twitter stream to (1) track rapidly-evolving public sentiment with respect to H1N1 or swine flu, and (2) track and measure actual disease activity. We also show that Twitter can be used as a measure of public interest or concern about health-related events. Our results show that estimates of influenza-like illness derived from Twitter chatter accurately track reported disease levels.

16 September 2019 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
RCRong Cai
Rong Cai
YZYu Zhang
Yu Zhang
JSJacob Simmering
Jacob Simmering
JSJordan Schultz
Jordan Schultz
YLYuhong Li
Yuhong Li
LLLei Liu
Lei Liu
Parkinson’s disease (PD) is a common neurodegenerative disease that lacks therapies to prevent progressive neurodegeneration. Impaired energy metabolism and reduced ATP levels are common features of PD. Previous studies revealed that terazosin (TZ) enhances the activity of phosphoglycerate kinase 1 (PGK1), thereby stimulating glycolysis and increasing cellular ATP levels. Therefore, we asked whether enhancement of PGK1 activity would change the course of PD. In toxin-induced and genetic PD models in mice, rats, flies, and induced pluripotent stem cells, TZ increased brain ATP levels and slowed or prevented neuron loss. The drug increased dopamine levels and partially restored motor function. Because TZ is prescribed clinically, we also interrogated 2 distinct human databases. We found slower disease progression, decreased PD-related complications, and a reduced frequency of PD diagnoses in individuals taking TZ and related drugs. These findings suggest that enhancing PGK1 activity and increasing glycolysis may slow neurodegeneration in PD.

1 January 2017 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
JSJacob Simmering
Jacob Simmering
FTFan Tang
Fan Tang
JCJoseph E. Cavanaugh
Joseph E. Cavanaugh
LPLinnea A. Polgreen
Linnea A. Polgreen
PPPhilip M Polgreen
Philip M Polgreen
Background: Outpatient therapies for urinary tract infections (UTIs) are becoming limited due to antimicrobial resistance. The purpose of this paper is to report how the incidence of hospitalizations for UTIs have varied over time in both men and women and across age groups. We also explore how the severity for UTI hospitalizations has changed and describe the seasonality of UTI hospitalizations. Methods: Using the Nationwide Inpatient Sample, we compute a time-series of UTI incidence and subdivide the series by age and sex. We fit a collection of time-series models to explore how the trend and seasonal intensity varies by age and sex. We modeled changes in severity using regression with available confounders. Results: In 2011, there were approximately 400000 hospitalizations for UTIs with an estimated cost of $2.8 billion. Incidence increased by 52% between 1998 and 2011. The rate of increase was larger among both women and older patients. We found that the seasonal intensity (summer peaks and winter troughs) increased over time among women while decreasing among men. For both men and women, seasonality decreased with advancing age. Relative to controls and adjusted for demographics, we found that costs among UTI patients grew more slowly, patients left the hospital earlier, and patients had lower odds of death. Conclusions: Incidence of UTI hospitalization is increasing and is seasonal, peaking in the summer. However, the severity of UTI admissions seems to be decreasing, indicating that patients previously treated as outpatients may now be admitted to the hospital due to increasing antimicrobial resistance.

4 March 2004 in New England Journal of Medicine
Verified
Journal Article
Open access
PDF file
CWCarolyn F. Williams
Carolyn F. Williams
DKDonna Klinzman
Donna Klinzman
TYTraci E. Yamashita
Traci E. Yamashita
JXJinhua Xiang
Jinhua Xiang
PPPhilip M Polgreen
Philip M Polgreen
JSJack Stapleton
Jack Stapleton
GB virus C (GBV-C), which is not known to be pathogenic in humans, replicates in lymphocytes, inhibits the replication of human immunodeficiency virus (HIV) in vitro, and has been associated with a decreased risk of death among HIV-positive persons in some, but not all, studies. Previous studies did not control for differences in the duration of HIV or GBV-C infection.

27 December 2019 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
AMAaron C. Miller
Aaron C. Miller
ACAlejandro P. Comellas
Alejandro P. Comellas
DHDouglas B. Hornick
Douglas B. Hornick
DSDavid A. Stoltz
David A. Stoltz
JCJoseph E. Cavanaugh
Joseph E. Cavanaugh
PPPhilip M Polgreen
Philip M Polgreen
Autosomal recessive diseases, such as cystic fibrosis (CF), require inheritance of 2 mutated genes. However, some studies indicate that CF carriers are at increased risk for some conditions associated with CF. These investigations focused on single conditions and included small numbers of subjects. Our goal was to determine whether CF carriers are at increased risk for a range of CF-related conditions. Using the Truven Health MarketScan Commercial Claims database (2001–2017), we performed a population-based retrospective matched-cohort study. We identified 19,802 CF carriers and matched each carrier with 5 controls. The prevalence of 59 CF-related diagnostic conditions was evaluated in each cohort. Odds ratios for each condition were computed for CF carriers relative to controls. All 59 CF-related conditions were more prevalent among carriers compared with controls, with significantly increased risk ( P < 0.05) for 57 conditions. Risk was increased for some conditions previously linked to CF carriers (e.g., pancreatitis, male infertility, bronchiectasis), as well as some conditions not previously reported (e.g., diabetes, constipation, cholelithiasis, short stature, failure to thrive). We compared our results with 23,557 subjects with CF, who were also matched with controls; as the relative odds of a given condition increased among subjects with CF, so did the corresponding relative odds for carriers ( P < 0.001). Although individual-level risk remained low for most conditions, because there are more than 10 million carriers in the US, population-level morbidity attributable to the CF carrier state is likely substantial. Genetic testing may inform prevention, diagnosis, and treatment for a broad range of CF carrier-related conditions.

1 June 2008 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
KWKevin L. Winthrop
Kevin L. Winthrop
SYS. Yamashita
S. Yamashita
SBS. E. Beekmann
S. E. Beekmann
PPPhilip M Polgreen
Philip M Polgreen
INInfectious Diseases Society Of America Emerging Infections Network
Infectious Diseases Society Of America Emerging Infections Network
We present the results of a nationwide survey of infectious disease consultants to identify mycobacterial and other serious infections in patients re